Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti-diabetic therapies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Atrial fibrillation and type 2 diabetes: Prevalence, etiology, pathophysiology and effect of anti-diabetic therapies
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-08-25
DOI
10.1111/dom.13512
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Thiazolidinediones and Risk of Atrial Fibrillation Among Patients with Diabetes and Coronary Disease
- (2018) Jannik Langtved Pallisgaard et al. AMERICAN JOURNAL OF MEDICINE
- Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke
- (2018) Yan-Rong Li et al. Cardiovascular Diabetology
- Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
- (2018) Karin Rådholm et al. CIRCULATION
- Predictive effect of hyperuricemia on left atrial stasis in non-valvular atrial fibrillation patients
- (2018) Fang-Zhou Liu et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Severe hypoglycemia is a risk factor for atrial fibrillation in type 2 diabetes mellitus: Nationwide population-based cohort study
- (2018) Seung-Hyun Ko et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Wider perioperative glycemic fluctuations increase risk of postoperative atrial fibrillation and ICU length of stay
- (2018) Ming Ann Sim et al. PLoS One
- Antihyperglycemic drugs use and new-onset atrial fibrillation in elderly patients
- (2017) Hung-Yi Chen et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial)
- (2017) Monique E. Cho et al. Journal of Clinical Hypertension
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum glycated hemoglobin level as a predictor of atrial fibrillation: A systematic review with meta-analysis and meta-regression
- (2017) Wenwei Qi et al. PLoS One
- Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study
- (2017) Sofia Dahlqvist et al. Lancet Diabetes & Endocrinology
- Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis
- (2017) Kåre I Birkeland et al. Lancet Diabetes & Endocrinology
- Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese Subjects
- (2016) Shabbar Jamaly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: The Look AHEAD randomized trial
- (2015) Alvaro Alonso et al. AMERICAN HEART JOURNAL
- High risk of abnormal QT prolongation in the early morning in diabetic and non-diabetic patients with severe hypoglycemia
- (2015) Tetsuro Tsujimoto et al. ANNALS OF MEDICINE
- Risk factors for atrial fibrillation in type 2 diabetes: report from the Swedish National Diabetes Register (NDR)
- (2015) Björn Zethelius et al. DIABETOLOGIA
- Role of Calcium-activated Potassium Channels in Atrial Fibrillation Pathophysiology and Therapy
- (2015) Jonas G. Diness et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Myocardial Fat Accumulation Is Independent of Measures of Insulin Sensitivity
- (2015) Ranganath Muniyappa et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparative cardiovascular safety of insulin secretagogues following hospitalization for ischemic heart disease among type 2 diabetes patients: a cohort study
- (2015) Yuhao Huang et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort
- (2015) Rajeev K. Pathak et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular safety of albiglutide in the Harmony programme: a meta-analysis
- (2015) Miles Fisher et al. Lancet Diabetes & Endocrinology
- Metabolic syndrome: a sympathetic disease?
- (2015) Markus Schlaich et al. Lancet Diabetes & Endocrinology
- Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study)
- (2015) Aki J. Käräjämäki et al. PLoS One
- Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)
- (2014) Omid Fatemi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies
- (2014) Shang-Hung Chang et al. Cardiovascular Diabetology
- Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats
- (2014) Shotaro Saito et al. CARDIOVASCULAR RESEARCH
- Contemporary Trends of Hospitalization for Atrial Fibrillation in the United States, 2000 Through 2010
- (2014) Nileshkumar J. Patel et al. CIRCULATION
- Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk
- (2014) Elaine Chow et al. DIABETES
- A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health Study
- (2014) Matthew Knuiman et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
- (2014) Aurora Merovci et al. JOURNAL OF CLINICAL INVESTIGATION
- Predisposing Factors Associated With Development of Persistent Compared With Paroxysmal Atrial Fibrillation
- (2014) Roopinder K. Sandhu et al. Journal of the American Heart Association
- Relationship Between Hypoglycemic Episodes and Ventricular Arrhythmias in Patients With Type 2 Diabetes and Cardiovascular Diseases: Silent Hypoglycemias and Silent Arrhythmias
- (2013) A. Stahn et al. DIABETES CARE
- Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study
- (2013) Deniz Karasoy et al. EUROPACE
- Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation
- (2013) Hany S. Abed et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relation of Heart-Rate Recovery to New Onset Heart Failure and Atrial Fibrillation in Patients With Diabetes Mellitus and Preserved Ejection Fraction
- (2012) Kazuaki Negishi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Lipid Metabolism and Toxicity in the Heart
- (2012) Ira J. Goldberg et al. Cell Metabolism
- Type 2 Diabetes Mellitus and Risk of Incident Atrial Fibrillation in Women
- (2012) Tobias Schoen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis
- (2011) E. Boettcher et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Association of the Metabolic Syndrome With Atrial Fibrillation Among United States Adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study)
- (2011) Rikki M. Tanner et al. AMERICAN JOURNAL OF CARDIOLOGY
- Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial Fibrillation
- (2011) Rachel R. Huxley et al. AMERICAN JOURNAL OF CARDIOLOGY
- Absolute and Attributable Risks of Atrial Fibrillation in Relation to Optimal and Borderline Risk Factors
- (2011) Rachel R. Huxley et al. CIRCULATION
- Association Between Lipid Profile and Risk of Atrial Fibrillation
- (2011) Hiroshi Watanabe et al. CIRCULATION JOURNAL
- Hypoglycemia and Cardiovascular Risks
- (2011) B. M. Frier et al. DIABETES CARE
- Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus
- (2011) J. Gu et al. EUROPACE
- Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study
- (2011) Rachel R Huxley et al. HEART
- Incidence of new onset bundle branch block and atrial fibrillation in patients with type 2 diabetes and macrovascular disease: An analysis of the PROactive study
- (2011) Roman Pfister et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes
- (2011) Tze-Fan Chao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Metabolic syndrome and atrial fibrillation in patients with essential hypertension
- (2011) G. Vyssoulis et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study
- (2010) Alanna M. Chamberlain et al. AMERICAN HEART JOURNAL
- Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation
- (2010) A. M. De Jong et al. CARDIOVASCULAR RESEARCH
- Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation
- (2010) Sascha Dublin et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation
- (2010) Usha B. Tedrow et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study
- (2009) X. Du et al. EUROPEAN HEART JOURNAL
- Influences of Autonomic Nervous System on Atrial Arrhythmogenic Substrates and the Incidence of Atrial Fibrillation in Diabetic Heart
- (2009) Hideki Otake et al. International Heart Journal
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Impact of New-Onset Diabetes Mellitus on Development of Atrial Fibrillation and Heart Failure in High-Risk Hypertension (from the VALUE Trial)
- (2008) Tonje Amb Aksnes et al. AMERICAN JOURNAL OF CARDIOLOGY
- Metabolic Syndrome and Risk of Development of Atrial Fibrillation
- (2008) Hiroshi Watanabe et al. CIRCULATION
- Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years
- (2008) T. S.M. Tsang et al. EUROPEAN HEART JOURNAL
- Atrial fibrillation and obesity—results of a meta-analysis
- (2007) Nikolas Wanahita et al. AMERICAN HEART JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now